Born with hepatitis, Adeline chooses to face her diagnosis

| June 27, 2018

article image
A young woman shares her story of living with hepatitis in the hopes of preventing others from making the same mistake she did. Watch as Adeline moves from denial of her hepatitis B diagnosis to empowerment as she learns to take control of her health

Spotlight

JAPARA HEALTHCARE LIMITED

Japara commenced business in 2005 as privately owned company and proceed to grow into one of Australia’s largest private sector operators of residential aged care facilities until publicly listing on the Australian Stock Exchange as Japara Healthcare Limited on the 17th April 2014.

OTHER ARTICLES

Tips for Managing Chronic Pain Beyond Prescription Painkillers

Article | February 17, 2020

Painkillers like Oxycontin, Percocet, and Vicodin, have been prescribed by primary physicians, surgeons, dentists, and other healthcare providers to patients suffering from varying levels of pain. Though these medications have proven to be an effective source of pain relief, they have also proven to be highly addictive. In fact, it has even been reported that there are more cases of a drug overdose and deaths from prescription painkillers than heroin or cocaine. While there are a number of factors that play into this opioid epidemic, educating doctors and patients on alternative solutions to managing chronic pain is a great place to start combatting this nationwide crisis.

Read More

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | February 17, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

How AI and Big Data Will Disrupt Pharma’s Regulatory Compliance Standards

Article | February 17, 2020

The industry as we know it is changing. Pharmaceutical and life sciences companies across the globe are experiencing more pressure than ever to keep up with increased regulatory standards while moving at a pace that requires them to innovate in order to remain competitive. With more real-time automation and the steady increase in AI and Big Data sweeping the landscape, what used to be a slow-to-change and risk-averse industry is now expected to see a significant shift towards newer technology that focus on heightened regulatory standards. Here’s how your company can get ahead of what industry experts are calling, Pharma

Read More

How Pharma Companies Can Scale Up Their Knowledge Discovery with Semantic Similarity Search

Article | February 17, 2020

Pharma has deep roots in human history with centuries of folk pharmaceutical knowledge offering a hit-and-miss range of natural remedies. But the industry as we know it today actually emerged in the second half of the 19th century when the world’s first factory for the sole production of medicines was found. By the late 19th and early 20th century, some chemical companies had already begun using research labs to explore the medical applications for their products. Fast forward to today and the pharmaceutical sector is a global trillion-dollar industry. However, to ensure the safety and efficacy of drugs, the process of drug discovery and development is under extensive scrutiny and control on both national and global levels.

Read More

Spotlight

JAPARA HEALTHCARE LIMITED

Japara commenced business in 2005 as privately owned company and proceed to grow into one of Australia’s largest private sector operators of residential aged care facilities until publicly listing on the Australian Stock Exchange as Japara Healthcare Limited on the 17th April 2014.

Events